Correlation Engine 2.0
Clear Search sequence regions


  • antigen (2)
  • bile duct (5)
  • female (1)
  • follow up studies (1)
  • glycogen (5)
  • GSK 3 (2)
  • gsk- 3α (2)
  • humans (1)
  • in 20 (1)
  • male (1)
  • patients (3)
  • prognosis (4)
  • protein human (1)
  • tissues (4)
  • XIAP (8)
  • xiap proteins (5)
  • Sizes of these terms reflect their relevance to your search.

    To investigate the expressions of the active form of glycogen synthase kinase-3(GSK-3)-pGSK-3α/β (Tyr279/216) and its downstream moleculor X-linked inhibitor of apoptosis protein (XIAP) in cholangiocarcinoma and to analyze their correlation with clinicopathological and survival significance. Immunohistoehemistry was used to detect the expressions of the active form of GSK-3- pGSK-3α/β (Tyr279/216) and its downstream moleculor XIAP proteins in 50 cholangiocarcinoma tissues and 20 normal bile duct tissues. The positive rates of pGSK-3α/β (Tyr279/216) and XIAP were 62.0% and 68.0% in cholangiocarcinoma, and 10.0% and 25.0% in normal bile duct tissues, respectively. The intensity of pGSK-3α/β (Tyr279/216) and XIAP expressions in cholangiocarcinoma were significantly higher than that in the normal bile duct tissues (P < 0.001), and there was a significant correlation between pGSK-3α/β (Tyr279/216) and XIAP expressions (r = 0.544, P < 0.001). The expression of pGSK-3α/β(Tyr279/216) protein in cholangiocarcinoma was associated with TNM stage (P = 0.042), histological grade (P = 0.031), whereas the expression of XIAP protein in cholangiocarcinoma was correlated with CEA level (P = 0.006). Patients with positive expression of pGSK-3α/β (Tyr279/216) and XIAP demonstrate a significantly worse prognosis than that of patients with negative expression of pGSK-3α/β (Tyr279/216) and XIAP for overall survival (P = 0.002, P = 0.018). Multivariate survival analysis revealed that positive pGSK-3α/β (Tyr279/216) expression provided significant independent prognostic value for overall survival (P = 0.002). The expressions of pGSK-3α/β(Tyr279/216) and XIAP proteins were significantly associated with the development and progression of cholangiocarcinoma. pGSK-3α/β(Tyr279/216) may be an important prognostic factor for survival of patients with cholangiocarcinoma.

    Citation

    Jie-wei Xu, Fan Zhou, Gui-xing Jiang, Cheng-yang Chen, Jing-jing Wang, Li-ping Cao. Expression of pGSK-3α/β Tyr279/216 and XIAP proteins in cholangiocarcinoma and their clinical significance]. Zhonghua zhong liu za zhi [Chinese journal of oncology]. 2013 May;35(5):366-71

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 24054014

    View Full Text